Overview

Tenofovir in HIV/HBV Coinfection

Status:
Completed

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to compare the effectiveness of 3 different treatment regimens in reducing or clearing the Hepatitis B Virus in patients infected with HIV and Hepatitis B (co-infection)

Phase:

Phase 4

Details

Lead Sponsor:

Kirby Institute

Collaborators:

Gilead Sciences
The University of New South Wales

Treatments:

Efavirenz
Lamivudine
Tenofovir
Zidovudine